Wikipedia -WSS

Wikipedia

author：fashion 2025-09-06 01:19:29 - browse：434

Insitro CEO and founder Daphne Koller Neilson Barnard/Getty Images for The New York Times

SAN FRANCISCO — It took only a single, one-hour meeting in a Starbucks to convince venture capitalist Robert Nelsen that he was going to invest in the company being built by machine-learning whiz Daphne Koller. “She’s just an amazing force of nature,” said Nelsen, who invests for ARCH Venture Partners.

Koller’s company, Insitro, in a matter of months raised over $100 million from big-name investors including ARCH, Foresite Capital, Andreessen Horowitz, and the firm that manages Jeff Bezos’ personal VC investments. (Koller refers to Bezos by his first name.) Now, it’s time for the next step. On Tuesday, the giant drug maker Gilead Sciences said it would pay Insitro $15 million — and up to $1 billion more down the line if it meets certain goals — for help in developing drugs to treat a common liver disease. It is the South San Francisco-based company’s first deal with a drug maker, and offers a test of whether artificial intelligence can remake drug development.

The very nature of the financials emphasize the exciting but risky reality: The technology has great promise, but nothing is guaranteed.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Color Health wants to make cancer screenings convenient

hotspot

WSS

Abortion pill mifepristone to soon be dispensed at CVS, Walgreens

Medicare Advantage isn’t working — for anyone

Kristina Burow of ARCH Venture Partners shares her next big bets STAT

Children’s Hospital revives plan for pedestrian bridge

Kale crackers and hibiscus tea: My five days on a 'fasting diet'

Elisabeth Bik tackles the widespread issue of research misconduct

explore

Wikipedia

leisure time

New air purifier tech could be key to improving indoor air quality

FogPharma raises $145 million in rare Series E round

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Obesity now affects over 1 billion people worldwide, study finds

Jerome Adams on the need for new antivirals for Covid

Flu vaccine offering decent levels of protection this winter, new data show

New air purifier tech could be key to improving indoor air quality

A Q&A with Aletha Maybank, AMA’s chief health equity officer

Hepatitis C has a cure — but many Americans still lack access to it

Cholera vaccine supplies dangerously low, outbreaks surging

knowledge

Change Healthcare cyberattack outage could last weeks

Pfizer is about to make a big push in cancer. Will investors listen?

FogPharma raises $145 million in rare Series E round

Clinical trials giant ICON acquires HumanFirst

ALS groups 'won't be played again' by the FDA, drug sponsors

Biotech companies concerned about China biosecurity crackdown

entertainment

hotspot

knowledge

Wikipedia